文献速递脑血管病

AP-1转录因子JunD通过IL-1β调控缺血再灌注脑损伤

AP-1 (Activated Protein-1) Transcription Factor JunD Regulates Ischemia/Reperfusion Brain Damage via IL-1β (Interleukin-1β).
PubMed 文献 · Stroke · 2019-01-01

研究探讨JunD在缺血再灌注脑损伤中的作用。野生型小鼠随机接受JunD或对照siRNA,进行45分钟大脑中动脉短暂闭塞再灌注24小时。JunD敲低加重梗死和神经功能缺损并增加系统性炎症,脑组织IL-1β升高;抗IL-1β抗体可逆转上述损害。急性缺血性卒中患者外周血单核细胞JunD表达在症状发作后6和24小时较健康对照降低。

要点

  • JunD敲低加重缺血再灌注脑损伤和神经功能缺损
  • JunD缺失增加脑组织IL-1β和系统性炎症
  • 抗IL-1β抗体可逆转JunD敲低的有害效应

核心结论

  • JunD通过抑制IL-1β减轻缺血再灌注诱导的脑损伤。

研究设计与样本

  • 野生型小鼠随机接受JunD或对照siRNA,行45分钟大脑中动脉短暂闭塞再灌注24小时。
  • 评估梗死体积、神经功能缺损、血浆/脑细胞因子及4-羟基壬烯醛免疫荧光氧化应激。
  • JunD siRNA小鼠再灌注时给予抗IL-1β单克隆抗体以探讨IL-1β作用。
  • 检测急性缺血性卒中患者外周血单核细胞JunD表达。

主要发现

  • JunD敲低导致梗死体积增加、神经功能下降和系统性炎症加重(中性粒细胞计数升高和淋巴细胞减少)。
  • JunD siRNA小鼠脑组织IL-1β水平较对照siRNA升高,而IL-6、TNF-α和4-羟基壬烯醛水平无差异。
  • 抗IL-1β抗体治疗可逆转JunD沉默的有害效应。
  • 急性缺血性卒中患者外周血单核细胞JunD表达在症状发作后6和24小时较性别年龄匹配健康对照降低。

关键数值与推荐

  • 小鼠大脑中动脉闭塞45分钟后再灌注24小时。
  • 再灌注24小时后评估梗死体积、神经功能缺损、血浆/脑细胞因子和4-羟基壬烯醛免疫荧光。
  • 患者外周血单核细胞JunD表达检测时间点为症状发作后6和24小时。

临床怎么用

  • JunD-IL-1β通路可能为缺血性卒中抗炎治疗提供潜在靶点。
  • 急性缺血性卒中患者外周血单核细胞JunD表达降低提示其作为生物标志物的潜在价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Inflammation is a major pathogenic component of ischemia/reperfusion brain injury, and as such, interventions aimed at inhibiting inflammatory mediators promise to be effective strategies in stroke therapy. JunD-a member of the AP-1 (activated protein-1) family of transcription factors-was recently shown to regulate inflammation by targeting IL (interleukin)-1β synthesis and macrophage activation. The purpose of the present study was to assess the role of JunD in ischemia/reperfusion-induced brain injury. Methods- WT (wild type) mice randomly treated with either JunD or scramble (control) siRNA were subjected to 45 minutes of transient middle cerebral artery occlusion followed by 24 hours of reperfusion. Stroke size, neurological deficit, plasma/brain cytokines, and oxidative stress determined by 4-hydroxynonenal immunofluorescence staining were evaluated 24 hours after reperfusion. Additionally, the role of IL-1β was investigated by treating JunD siRNA mice with an anti-IL-1β monoclonal antibody on reperfusion. Finally, JunD expression was assessed in peripheral blood monocytes isolated from patients with acute ischemic stroke. Results- In vivo JunD knockdown resulted in increased stroke size, reduced neurological function, and increased systemic inflammation, as confirmed by higher neutrophil count and lymphopenia. Brain tissue IL-1β levels were augmented in JunD siRNA mice as compared with scramble siRNA, whereas no difference was detected in IL-6, TNF-α (tumor necrosis factor-α), and 4-hydroxynonenal levels. The deleterious effects of silencing of JunD were rescued by treating mice with an anti-IL-1β antibody. In addition, JunD expression was decreased in peripheral blood monocytes of patients with acute ischemic stroke at 6 and 24 hours after onset of stroke symptoms compared with sex- and age-matched healthy controls. Conclusions- JunD blunts ischemia/reperfusion-induced brain injury via suppression of IL-1β.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Diaz-Cañestro C, Reiner MF, Bonetti NR, et al. AP-1 (Activated Protein-1) Transcription Factor JunD Regulates Ischemia/Reperfusion Brain Damage via IL-1β (Interleukin-1β). Stroke. 2019. PMID: 30626291. doi:10.1161/STROKEAHA.118.023739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。